Invented and manufactured by the pharmaceutical giant Bayer, Xarelto is an oral anticoagulant designed to prevent blood clots by inhibiting factor Xa. It is marketed by Janssen Pharmaceutical as Xarelto, and it is the first orally active direct factor Xa inhibitor.
On July 1, 2011, the FDA approved the ...